로딩 중…
지수 로딩 중…
제이투케이바이오
420570· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩7,110-1.25%
2026-06-19
Price Chart
제이투케이바이오-30.84%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 41.58B KRW |
| Revenue | 36.82B KRW |
| Net Income | 712.6M KRW |
| Total Assets | 41.05B KRW |
| Net Assets | 33.90B KRW |
| Employees | 56 |
| Value | |
| P/E | 58.34x |
| P/B | 1.23x |
| PEG | 0.10x |
| P/S | 1.13x |
| EV/EBITDA | 14.89x |
| FCF Yield | 3.56% |
| Profitability | |
| ROE | 2.10% |
| ROA | 1.74% |
| Op. Margin | 6.04% |
| Revenue Growth | 53.08% |
| Earnings Growth | 567.57% |
| Financial Health | |
| Debt Ratio | 121.09% |
| Total Debt | 400.0M KRW |
| FCF | 1.48B KRW |
| Cash | 8.88B KRW |
| Current Ratio | 3.74x |
| Net Debt/EBITDA | -3.81x |
| Dividend | |
| Div. Yield | 3.47% |
| Div. Growth | 25.00% |
| Performance | |
| 1Y Return | -30.84% |
| 1M Return | -33.86% |
| From 52W High | -40.00% |
| 1Y MDD | -44.32% |
| Trading | |
| Volume | 42,760 shares |
| Foreign Own. | 1.36% |
| Per Share | |
| EPS | 689 KRW |
| BPS | 5,798 KRW |
Company Info
J2K Bio, established in 2016 and listed on KOSDAQ in March 2024, produces and sells cosmetic raw materials. The company is a cosmetic new material developer that swiftly meets client demands through innovative natural product methods and new material development using fermented microorganisms, offering a competitive edge. It focuses on developing new active ingredients derived from natural, organic, and biomaterials, providing safer alternatives to synthetic compounds. J2K Bio is headquartered in Cheongju-si, Chungcheongbuk-do.